Giammarco Mocci

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants

Gianluca Andrisani, Daniela Frasca, Maria Romero et al. · Journal of Crohn s and Colitis · 2012 · 92 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

Luisa Guidi, Manuela Marzo, Gianluca Andrisani et al. · Digestive and Liver Disease · 2014 · 89 citations

Life Sciences, Immunology, Immunopathology +16

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents

Alfredo Papa, Carla Felice, Manuela Marzo et al. · Journal of Crohn s and Colitis · 2012 · 73 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

Antonio Tursi, Giammarco Mocci, Roberto Lorenzetti et al. · European Journal of Gastroenterology & Hepatology · 2021 · 49 citations

Pharmacy, Immunology, Pharmacotherapy +14

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

Sara Onali, Daniela Pugliese, Flavio Caprioli et al. · The American Journal of Gastroenterology · 2022 · 49 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16